GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
1 clinical trials · Sponsor
◉ Watch GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
| Record | Firm | Date |
|---|---|---|
| GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma (NCT04060342) | GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2019-08-13 |
Track GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.